Grounds 1(a) and 1(c): Scope of Practice and Supervision of Associates
Grounds 1(a) and 1(c): Scope of Practice and Supervision of Associates
Claimants’ Submissions
The claimants’ (and BMA’s) case is that there has been, and continues to be, a failure by the defendant to exercise its powers in relation to the creation of the new regulatory regime lawfully. The regime requires the introduction by the defendant of safe and lawful practice measures. The claimants’ pleaded case is that the only rational exercise of the regulatory powers contained in the 2024 Order is by the setting of nationally applicable limits on practice by reference to specific tasks which the associate profession are prohibited from undertaking even under supervision and irrespective of their post-qualification practice (and presumably experience). The limits should be set by the defendant or, if by a third party, then endorsed by the defendant.
The SFG sets out examples of the “outer limits or ceilings” beyond which it would never be appropriate for an associate to act instead of a qualified doctor. They include the prohibition on associates administering anaesthesia in paediatric or obstetric cases or other risky and complex cases such as major surgery on a patient with severe systemic disease (though provision could be made for genuine emergency situations). In oral submissions Mr de la Mare added the further example of a prohibition on associates seeing undifferentiated patients. These various prohibitions would remain even if the competency of associates evolves in their post-qualification practice.
Although the claimants’ submissions do not differentiate between the two, the challenge encompasses both process irrationality and outcome irrationality. Mr Dunlop submits that the claimants’ pleaded claim relates to the irrationality of the outcome, not the process by which it arrived at the outcome. The scope of the claimants’ case is therefore an issue for me to resolve.
The claimants’ main submissions (on both process and outcome rationality) are set out below. Many of the points which are made are derived from (or critique) the witness statements of Professor Melville. As I understand the claimants’ position, however, they do not accept that the reasoning and rationale in those statements is a true reflection of the defendant’s thinking at the time. Mr de la Mare points out that there is no contemporaneous document or set of documents in which the defendant appears to have grappled with the central issues concerning limits of practice and supervision or the evidence bearing on those questions. Further, the defendant’s initial response to the claim (in pre-action correspondence) challenged the existence of a power which would permit the defendant to impose limits of practice. Given this position, the claimants suggest that it is unlikely that the defendant gave any thought at all to the need for limits on practice and that from the outset the defendant adopted a “bright line” approach that such limits on scope of practice would not be part of the regulatory regime. The contents of Professor Melville’s witness statements are after-the-event rationalisations for the purpose of this litigation. As such, it is submitted they are not admissible to explain the defendant’s reasoning and I should disregard them. See R v Westminster City Council, ex parte Ermakov [1996] 2 All ER 302.
Notwithstanding this point, the claimants make the following submissions:
The defendant’s starting point was wrong. To apply the medical model to associate regulation fails to recognise that doctors and associates belong to fundamentally different professions. As such, the approach taken by the defendant from the outset was misconceived as a matter of principle. Associates present what Mr de la Mare characterises as a “systemic risk” to patient safety because the limited nature of their training and expertise means that an associate will be unable to recognise their own limits of competence. The requirement in GMP that the associate adheres to a standard which requires the associate to work within the limits of their competence is therefore meaningless. It is equally difficult for the doctor bearing the responsibility of supervising the associate to know what tasks the associate is capable of performing.
Having adopted the wrong starting point, the defendant then compounded the error by taking the approach that it could only deviate from the starting point in the face of ‘compelling evidence’. Mr de la Mare submits that the origin of what he labels the “compelling evidence test” is not clear. It is not derived from the 2024 Order and it does not appear in any of the contemporaneous documents. Wherever it came from, it is the wrong test.
Even if the compelling evidence test were lawful (which he does not accept), Mr de la Mare submits that there is no evidence that the test was ever applied by the defendant. Had it been applied, the only rational response to the serious concerns raised by the defendant’s own COI survey, by surveys undertaken by third parties (including the BMA), by coroners and by doctors would have been for the defendant to issue a scope of practice for associates or, at least, adopt and endorse a scope of practice published by another professional body.
Mr de la Mare’s oral submissions included a detailed analysis of the COI survey and subsequent surveys which, he says, provide more than compelling evidence that patient safety was and continues to be put at risk by the defendant’s continuing failure to devise safe ceilings of practice for associates. The responses to the COI survey demonstrated comprehensive concerns over patient safety arising from associates working outside their competence and a lack of understanding by the public of the role of associate. Neither the associates themselves nor their wider healthcare team are able to identify the limits of their competence, which is essential to ensuring safe delegation and supervision. Those concerns were then echoed in the BMA survey and the survey undertaken by DAUK. The results of the surveys all tally. Further, the later RCGP survey demonstrated that a large majority of respondents had concerns over patient safety and for over 60% of respondents PAs were the first point of contact of undiagnosed/undifferentiated patients. The PFD reports were highly relevant. Mr de la Mare submitted that “any regulator would look at them and say that the documents should be seen, and consideration given to whether the current course is justifiable”. In short, there was, he submits, a large amount of relevant material which the defendant should have grappled with. Had the defendant done so, whatever its starting position, it should have changed course and introduced limits on practice. Not to do so was irrational.
The responses to the COI Survey demonstrate that doctors have repeatedly experienced issues in safely delegating to, and determining safe supervision levels for, associates because they cannot easily determine their competence. These concerns, of which the defendant was aware and which were closely linked to the absence of a scope of practice, posed serious risks to patient safety.
The defendant’s reliance upon the role of the Trust employing the associate in determining safe limits of practice was misplaced and irrational. It fails to recognise that the employers are “part of the problem and not the cure”. Trusts are financially and otherwise motivated (eg to reduce waiting lists) to push the boundaries of what associates can do. The fact that Trusts are subject to clinical governance controls themselves and overseen in various ways by other bodies is irrelevant. This oversight existed before regulation and is not designed to, and does not, deal with associate-specific issues. Ms Richards adds that the reliance upon locally determined limits on practice will inevitably (and indeed already has) led to variability and lack of clarity as between different NHS Trusts. Further, the defendant’s approach to regulation ignores the reality of NHS working patterns which may mean that doctors may frequently need to delegate to an associate they have never worked with before (and therefore do not have any understanding of their skills, training or competence) under significant time pressure.
Even if the defendant is correct to say that it is not best-placed to set limits for associates (which again, the claimants do not accept) in the circumstances it was incumbent upon it to ‘come off the fence’ where the Royal Colleges or other bodies had published scopes of practice and endorse them either in their entirety or those specific parts which it agreed with. The failure to do so is irrational.
The defendant’s current regulatory model relies upon quality assured pre-qualification associate training, the power to bring fitness to practise proceedings against associates, and the forthcoming revalidation system. This is insufficient to address the systemic risks posed by associates. This is because (i) the regulation of pre-qualification training does not address those associates who are already working in the system; (ii) fitness to practise proceedings are by definition ex post facto responses to harm which has already occurred, and they are not useful in addressing systemic issues as opposed to individual failings; and (iii) the adequacy of the fitness to practise and revalidation systems are undermined by the lack of a national scope of practise.
Finally, Mr de la Mare submitted that in reaching its judgement upon how to exercise its powers under the 2024 Order rationally, the defendant was required to consider and assess the potential risks to patient safety and take rational precautions to avoid those risks. In so doing, it should have erred on the side of caution, in particular by not relying upon uncertainty about the risk eventuating. This, he says, accords with the “precautionary principle” see (R (TransActual CIC) v SSHSC [2025] PTSR and R (Plan B Earth) v Secretary of State for Transport [2020] EWCA Civ 214 at para 258 – 261).
The BMA echoes the claimants’ submissions. Ms Richards KC additionally challenged the most recent guidance from the defendant on supervision (the Supervision Practice Advice of April 2025) which requires doctors to ‘establish what care [associates] can undertake.’ This, submits Ms Richards, begs the question of how doctors are supposed to do so in the absence of any national scope of practice or guidance endorsed by the defendant.
She submits that the current supervision requirements impose unrealistic demands upon individual supervising doctors who are left to work out how to approach supervision and delegation. Furthermore, far from assisting doctors, it makes matters worse by in some instances being internally inconsistent and presenting a contradictory message. As an example, she cites how the document refers readers to various non-statutory guides including various interim scopes of practice published by the RCA and the RCGP as well as advice published by the College of Medical Associate Professionals, the MAPS Employer Guidelines General Practice 2024. That guidance explicitly disavows the BMA and RCGP’s Scope of Practice, but also sets out (in an example job description for PAs) various tasks such as providing the first point of contact with undifferentiated patients, ‘baby checks’, minor surgeries, and holding telephone conferences with patients. All of these tasks, however, fall outside the RCGP’s 2024 scope of practice. This begs the question – what is a named supervising doctor, who has now been saddled with the obligation to work out what associates can or cannot do when delegating tasks to them, to do when presented with this contradictory information? She submits that it must be that it is both perverse and unfair to doctors to place the burden of navigating through this uncertainty upon their shoulders.
Defendant’s submissions
Mr Dunlop raises a preliminary objection to the scope of the claim in Ground 1. He contends that Ground 1 of the claim as pleaded is limited to an outcome rationality challenge to an ongoing state of affairs. He draws my attention to the pleaded case, which concerns the defendant’s ‘ongoing failures’ to impose the safe and lawful practice measures; and that this was reflected not only in the claimants’ SFG, but also the claim formand the relief sought (a declaration that the defendant is failing to fulfil its duties and lawfully exercise its powers). These are outcome rationality arguments. During the course of the claimants’ oral submissions, the arguments have been reframed to include process rationality arguments (e.g., that the defendant had adopted the wrong starting point; or that it had failed to reconsider its approach in the light of emerging evidence which allegedly establishes that associates pose a systemic risk to patient safety). This, Mr Dunlop submits, is impermissible. Had a process rationality complaint been pleaded, the defendant may have filed evidence directed to the particular aspects of the alleged flawed process, may have reconsidered one or more issues in a new formal decision or may have raised a defence under s. 31(3D) of the Senior Courts Act 1981. Mr Dunlop does not go so far as to submit that, when considering the rationality of the outcome, I should disregard the process by which the decision was reached. He accepts that the process may affect the margin of discretion available to the defendant. But he submits that the sole question for the court remains whether the outcome falls outside the range of reasonable responses. The case is about the defendant’s failure to set nationally applicable hard limits on what associates can (or cannot) do, whatever their experience, even under supervision.
The defendant denies that the current regulatory regime is “hollow” and rejects the complaint that it has done nothing meaningful to address the risks posed by associates. The defendant highlighted the requirements for registration (to become mandatory by December 2026), revalidation (albeit that this system is still currently being developed), and the fitness to practise process. In short:
The defendant has set standardised learning outcomes and educational standards which will assist associates with understanding the limits of their competence.
Associates who are already practising in the system (and therefore not subject to these new training standards) are required to meet the training standards in order to be registered; and those who fail to provide adequate evidence or simply fail to meet those standards will not be able to work as associates after December 2026.
The forthcoming revalidation system will involve a five-yearly formal process, but it is anticipated that there will be annual appraisals at the employer level. Those are expected to consider whether the associate has been acting within the scope of their practice (and whether there have been any adverse clinical incidents). The information from the annual appraisals will be highly relevant to the five-year formal revalidation. As before, a failure to meet the relevant standards will mean that an associate will not be revalidated and therefore cannot continue practising.
Where there are serious concerns which arise during the annual or formal appraisals which cannot be dealt with locally, it is expected that these will lead to fitness to practise proceedings being brought against the associate. As with doctors, there will be a range of sanctions which can be imposed for a breach of professional standards, ranging from imposing conditions on practice to suspension up to removal from the register.
The defendant accepts that the principal purpose of the 2024 Order is to protect the public, just as with the regulation of doctors the overarching function of regulation is patient safety. The defendant also accepts that its own COI survey raised serious concerns from a range of respondents about associates working beyond their competence; inadequate supervision of associates; associates failing to explain who they are to patients and patients themselves not knowing and understanding who associates are. The defendant accepts that those concerns were echoed in surveys conducted by others and in the coronial reports and that those concerns needed to be addressed. The question which arises in this claim is not whether there are concerns over safe associate practice but how those concerns are best addressed, whether they require the introduction of limits on practice and by whom they should be addressed. The claimants’ case is that those concerns can only, rationally, be addressed by the imposition of (further) limits on associates’ practice and that those (further) limits must be imposed by the defendant. For a number of reasons, including those set out in Professor Melville’s evidence, the defendant takes a different view.
Mr Dunlop submits that, logically, the case breaks down into two questions. First, whether it would be of net benefit to public protection for limits to be set on associates’ practice. Second, if so, is it irrational for the defendant not to set such limits.
Concerning the first question, Mr Dunlop accepts that there is scope for disagreement about whether national limits on associates’ practice further patient safety and that it is a topic upon which reasonable people may disagree. The claimants have presented the court with one side of the argument but, he argues, there is another side. There are “pros and cons” to the imposition of limits on the practice of associates. Mr Dunlop submits that I must be careful not to enter the debate and seek to resolve it. This would not only be an impermissible exercise of the court’s function but is a role the court is not equipped to fulfil. The court’s role in this application is limited to answering the question of whether the defendant’s approach is rational and therefore lawful.
An important downside to the imposition of limits on associates’ practice is that it might unduly restrict the contribution which associates can make to the NHS both now and in the future. Mr Dunlop submits that there is abundant evidence of a looming healthcare workforce gap over the next ten or so years. In this context associates will make an important contribution. The DHSC’s consultation document (which accompanied a draft of the 2024 Order) set out that “strengthening the future NHS workforce remains one of the government’s priorities.” It continued: “..associates are already a valued and integral part of the multi-disciplinary healthcare team but have the potential to make an even greater contribution.. The GMC is best placed to regulate the AAs and PAs as they form part of the medical team and are trained to the medical model. Regulation also paves the way for broadening their scope of practice by, for example requesting ionising radiation where local governance allows and, in the future, the possibility of being able to prescribe.” Mr Dunlop drew my attention to correspondence from the Academy of Medical Royal Colleges (the umbrella body for all Royal Colleges) to the BMA dated 6 March 2024 which suggested that broad profession-wide limits of practice were inappropriate. The author pointed to the dangers of broad profession wide limits commenting that the issue of scope of practice is “a complex issue which is both location and specialty specific.”
Mr Dunlop submitted that the best account of the pros and cons of imposing limits on associates’ practice is provided by the Professional Standards Authority’s (“the PSA”) submissions to the Leng Review dated March 2025. The PSA oversees all healthcare regulators. The Leng Review was set up by the government in autumn 2024. It is an independent review of the physician associate and anaesthesia associate professions by Professor Gillian Leng for the purpose of agreeing recommendations for the future. It will consider the safety of the roles and their contribution to multidisciplinary healthcare teams. It is described as an “end to end” review of associates’ practice covering; selection and recruitment; training; day to day work; scope of practice; oversight; supervision; professional regulation.
The PSA’s position on the topic of limits on practice is neutral. The object of the paper submitted to Professor Leng was to set out considerations in relation to scopes of practice of health and care professionals. It remarked that the issue of limits on practice had been central to debates about the safety of the physician associate and anaesthesia associate roles.
The PSA paper sets the question of limits on practice in context. The authors note that scopes of practice have not been a significant feature of professional regulation within the UK to date and that in the UK, the GDC is the only regulator to have defined scopes of practice for the roles which it regulates. The PSA has not, to date, taken a formal position in relation to the role of scopes of practice within professional regulation but it has been supportive of the GDC’s proposals to build greater flexibility into their scopes of practice for the dental team. It noted that scopes of practice have been relevant to debates about the regulation of advanced nursing practice and that for “several years now, people have been raising concerns about nurses and other professions working at an advanced level, undertaking tasks which, they argue, go beyond the scope of practice and training of registrants.”
The PSA highlights the scale of the workforce change which will be needed to deliver healthcare in the future with increasingly challenging economic and social circumstances, with an aging population with increasingly complex needs. This will require the development of new roles, and the evolution of existing roles. It is in the context of this potential work force gap that the PSA considered some of the unintended consequences, or potentially significant downsides, of defined scopes of practice. The PSA noted that the unintended consequences of defined scopes of practice was likely to be one of the central questions for Professor Leng.
The unintended consequences may include:
hindering workforce flexibility and preventing adaptation to fast-paced changes in healthcare delivery which came into sharp focus during the pandemic;
where scopes of practice are defined, a ‘calcifying effect’ upon the boundaries between different medical professions, in which scopes of practice may be used as a mechanism to enforce ‘occupational closure’ where any attempt to shift tasks or limits can trigger professional boundary disputes;
indemnifiers who have a stake in the scope of practice debate may use them to determine the boundaries of indemnity cover;
even where scopes of practice are not intended to be defined tightly this can be how they are interpreted by professionals – an indicative list of tasks can become an exhaustive list in the eyes of the professionals as was the case in the GDC;
the PSA noted that ‘[w]hile it may be necessary for scopes of practice to be set, it may not be necessary for this to be done by the professional regulator … Royal Colleges and professional bodies can also play a part here’;
The PSA concluded that optimising flexibility in the workforce is going to be a matter of increasing importance and “so we need to think carefully about how we balance this with safety and accountability.”
Mr Dunlop argues that the submission of the PSA to the Leng Review illustrates that the question of limits on practice is a complex issue which engages policy and political issues. The complexity and the nature of the issues engaged is further demonstrated by the fact of the Leng Review itself. Mr Dunlop agrees with the claimants that the Leng Review is of limited relevance to the claim, in the sense that Professor Leng’s conclusions, one way or another, will not have a direct bearing on the lawfulness of the decision making of the defendant. He submits however that the fact that the review is considering scope of practice and all aspects of associates’ working illustrates why it would be inappropriate for this court to rule on the topic. Importantly, the fact of the review underlines the inherently political and policy-based nature of the issues raised in the claim. Mr Dunlop therefore submits that it would be inappropriate for the court to resolve them even if there were not a review currently underway. Mr Dunlop submitted that it was not for me to “wade in” and rule on the rights and wrongs of the imposition of scopes of practice. The task of regulation had been entrusted by government to the defendant, and not to the court or the claimants and that it is not “for judges to weigh utilitarian calculations of social, economic or political preference.” I should guard against the danger of judges “wrongly though unconsciously substituting their own views for the views of the decision-maker who alone is charged and authorised by Parliament to exercise a discretion” see R v Secretary of State for Trade and Industry ex p Lonrho Plc [1989] 1 WLR 525) at 535. A Wednesbury challenge should not be used as “cover” for the court to impose what it considers as ideal solutions.
The question of whether to impose detailed profession-wide limits on the practice of PAs and AAs is a complex multi factorial policy question which is not appropriate for a court to determine in a claim for judicial review. It does not matter whether or not the defendant considered each (or any) of the factors informing the debate when determining not to impose limits on associates’ practice. The fact is there is a debate and it is one which engages policy and politics. This means that the outcome rationality ground must inevitably fail. The court cannot rule on whether the premise of the claimants’ criticisms is correct.
Mr Dunlop says that even if I were to find against him on the first question, the claimants have still failed to show that it was irrational for the defendant not to have set those limits. There are five main reasons for this submission:
First, the court should take into account the defendant’s own experience of regulating doctors. It was reasonable for the defendant to take this experience into account. Its understanding drawn from that experience was (and continues to be) that the imposition of high level principles can be an effective means of regulation.
Second, the defendant refers to the consistent advice it received from other regulators not to set detailed limits on associates’ tasks. These arose out of separate meetings on 7 October 2019 with the Nursing and Midwifery Council and the GDC. The latter advised the defendant to ‘avoid defining role or scope of practice as that inhibits growth of the profession and the role.’
Third, the defendant lacks expertise in specific fields of clinical management. The Royal Colleges and individual employers are best placed to devise appropriate scopes of practice. As the Academy of Royal Colleges said in its letter to the BMA on 6 March 2024 (in response to the BMA’s scope of practice) ‘it would be inappropriate for the BMA to set out the scope of practice for [Associates] … it is clear that [curricula and professional practice] falls firmly within our area of responsibility’ (emphasis added). Outside of this litigation both the First Claimant and the BMA have made statements that align with the defendant’s argument that it is not best placed to set limits of practice. Mr Dunlop draws my attention to the First Claimant’s website entry on 30 January 2024 that the defendant “does not have the knowledge to define the standards of practice in each of the many different branches of medicine.” In its submission to the Leng Review, the BMA recommended that there should be nationally agreed scopes of practice, not drafted by the defendant, but “led by medical royal colleges, specialist medical organisations and the BMA with input from associate representatives and patient organisations.”
Fourth, the DHSC’s commentary on a draft of the 2024 Order (addressed to the defendant), and its response to its 2023 consultation, indicated that it expected the defendant to set standards of the kind it set for doctors under s. 35 MA 1983 – which would not include limits on practice but instead comply with the general requirement that they must ‘recognise and work within their competence’.
Fifth, the 2024 Order does not require the defendant to impose limits on the clinical tasks which associates may undertake. Had Parliament considered this necessary, it would have included an express duty on the defendant to do so. Moreover, the wording of Art. 3 of the 2024 Order mirrors that of s. 35 MA 1983. It follows that even ignoring what the DHSC had to say, Parliament itself expected the defendant to set high-level standards for associates in the same way it did for doctors.
- Heading
- Mrs Justice Lambert DBE
- Background
- The Statutory Framework
- The 2024 Order
- Good Medical Practice and other guidance and advice issued by the GMC
- Supervision
- Claimants’ Evidence of Risk to Patient Safety
- Coroners’ investigations and Prevention of Future Death reports
- Mr Benedict Peters
- Mrs Pamela Ann Marking
- The Defendant’s Evidence: Professor Melville
- Scope of Practice and Supervision
- Ground 1
- Grounds 1(a) and 1(c): Scope of Practice and Supervision of Associates
- Ground 1(c): the Supervision and Delegation issue
- Ground 1: Discussion/Conclusion The scope of Ground 1: process and outcome rationality
- Ground 1(a) and Ground 1(c): process irrationality
- Outcome Irrationality
- Ground 1(b): Informed Consent
- Ground 1(b): Discussion/Conclusion
- Ground 2: Tameside duty of inquiry
- Ground 2 Discussion
- Conclusions
![AC-2024-LON-003354 - [2025] EWHC 2270 (Admin)](https://backend.juristeca.com/files/emisores/logo_fi51A75.png)